Cargando…

SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy

Rationale: The circadian clock coordinates cell proliferation and metabolism and impacts the progression of some diseases, particularly cancer. Pharmacological modulation of the circadian machinery may be an effective therapeutic approach for treating cancer. SR9009 is a specific synthetic agonist o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Weitao, Zhang, Wei, Ye, Weilin, Wang, Haihong, Zhang, Qingxi, Shen, Jie, Hong, Qingsha, Li, Xiang, Wen, Ge, Wei, Ting, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150483/ https://www.ncbi.nlm.nih.gov/pubmed/32292508 http://dx.doi.org/10.7150/thno.42478

Ejemplares similares

In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011
por: Geldof, Lore, et al.
Publicado: (2016)

SR9009 improves heart function after pressure overload independent of cardiac REV-ERB
por: Li, Hui, et al.
Publicado: (2022)

REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish
por: Saiz, Nuria, et al.
Publicado: (2022)

Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells
por: Wagner, Paula M., et al.
Publicado: (2019)

SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs
por: Xu, Hang, et al.
Publicado: (2022)

Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway
por: Sheng, Mingyue, et al.
Publicado: (2023)

Circadian Clock REV-ERBs Agonist SR9009 Induces Synergistic Antitumor Activity in Multiple Myeloma by Suppressing Glucose-Regulated Protein 78-Dependent Autophagy and Lipogenesis
por: Wang, Rui, et al.
Publicado: (2023)

The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock
por: Ishimaru, Kayoko, et al.
Publicado: (2019)

SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis
por: Hu, Ming, et al.
Publicado: (2022)

Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence
por: Gao, Li‐Bin, et al.
Publicado: (2021)

Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model
por: Yue, Jiong, et al.
Publicado: (2020)

Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ
por: Cho, Han, et al.
Publicado: (2012)

The Effect of Rev-erbα Agonist SR9011 on the Immune Response and Cell Metabolism of Microglia
por: Wolff, Samantha E. C., et al.
Publicado: (2020)

REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output
por: Ikeda, Ryosuke, et al.
Publicado: (2019)

REV-ERB is essential in cardiac fibroblasts homeostasis
por: Luo, Xiaokang, et al.
Publicado: (2022)

Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle
por: Amador, Ariadna, et al.
Publicado: (2018)

Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
por: Liu, Qingxue, et al.
Publicado: (2021)

Downregulation of REV-ERBα is associated with the progression of lung adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2022)

Direct Regulation of CLOCK Expression by REV-ERB
por: Crumbley, Christine, et al.
Publicado: (2011)

Rev-erbs and Glia—Implications for Neurodegenerative Diseases
por: Griffin, Percy, et al.
Publicado: (2019)

The Role of REV-ERB Receptors in Cancer Pathogenesis
por: Gomatou, Georgia, et al.
Publicado: (2023)

Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy
por: Woldt, Estelle, et al.
Publicado: (2013)

SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome
por: Reitz, Cristine J., et al.
Publicado: (2019)

REV-ERBα reduction is associated with clinicopathological features and prognosis in human gastric cancer
por: Wang, Xiaoshan, et al.
Publicado: (2018)

Circadian Clock Genes REV-ERBs Inhibits Granulosa Cells Apoptosis by Regulating Mitochondrial Biogenesis and Autophagy in Polycystic Ovary Syndrome
por: Sun, Lihua, et al.
Publicado: (2021)

Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation
por: Amador, Ariadna, et al.
Publicado: (2016)

Expression of AFP and Rev-Erb A/Rev-Erb B and N-CoR in fetal rat liver, liver injury and liver regeneration
por: Meier, Volker, et al.
Publicado: (2006)

Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists
por: Solt, Laura A., et al.
Publicado: (2012)

Novel Function of Rev-erbα in Promoting Brown Adipogenesis
por: Nam, Deokhwa, et al.
Publicado: (2015)

Rev-erbα in the brain is essential for circadian food entrainment
por: Delezie, Julien, et al.
Publicado: (2016)

Targeting REV-ERBα for therapeutic purposes: promises and challenges
por: Wang, Shuai, et al.
Publicado: (2020)

NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process
por: Shen, Weitao, et al.
Publicado: (2022)

REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice
por: Shao, Ruyue, et al.
Publicado: (2021)

Myocardial Rev-erb–Mediated Diurnal Metabolic Rhythm and Obesity Paradox
por: Song, Shiyang, et al.
Publicado: (2022)

Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells
por: De Mei, C, et al.
Publicado: (2015)

The nuclear receptor REV-ERBα is implicated in the alteration of β-cell autophagy and survival under diabetogenic conditions
por: Brown, Matthew R., et al.
Publicado: (2022)

Exercise alters the circadian rhythm of REV-ERB-α and downregulates autophagy-related genes in peripheral and central tissues
por: da Rocha, Alisson L., et al.
Publicado: (2022)

Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease
por: Kim, Jeongah, et al.
Publicado: (2022)

The Nuclear Receptor Rev-erbα Controls Circadian Thermogenic Plasticity
por: Gerhart-Hines, Zachary, et al.
Publicado: (2013)

REV-ERBα influences the stability and nuclear localization of the glucocorticoid receptor
por: Okabe, Takashi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_56khvkhm5r1aot7bq8gfl9soh5